Research and PublicationsLauren E. Guest

Peer-Reviewed Articles

1. Tapper, Elliot, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair, Afdhal, Nezam. 2016. “Real-world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study.” Journal of Viral Hepatitis 24(1): 22-27.

2. Guest, Lauren, Schap, David, Tran, Thi. 2015. “The ‘Loss of Chance’ Rule as a Special

Category of Damages in Medical Malpractice Cases: A State-by-State Analysis.” Journal of Legal Economics 21(2): 53-107.

3. Schap, David, Baumann, Robert, Guest, Lauren. 2014. “Wage Net Discount Rates: 1981-2012.” Journal of Forensic Economics 25(2): 153-174.

4. Guest, Lauren, Schap, David. 2014. “Rationales Concerning the Treatment of Federal Income Taxes in Personal Injury and Wrongful Death Litigation in the State Courts.” Journal of Legal Economics 21(1): 85-117.

5. Guest, Lauren, Schap, David. 2014. “Case Law Concerning the Treatment of Federal Income Taxes in Personal Injury and Wrongful Death Litigation in the State Courts.” Journal of Legal Economics 20(1-2): 85-123.

6. Schap, David, Guest, Lauren, Kraynak, Andrew. 2013. “Total Offset and Medical Net Discount Rates: 1981-2012.” Journal of Forensic Economics 24(2): 191-204.

Conference Talks

1. Younossi, Zobair, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Afdhal, Nezam. 2016. “Access to Therapy in Era of All DAA Regimens: Real World Experience from the TRIO Network.” Digestive Disease Week. San Diego, California.

2. Kowdley, Kris, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Lee, Yoori, Tsai, Naoky, Younossi, Zobair, Afdhal, Nezam. 2016. “Ledipasvir/Sofosbuvir +/- Ribavirin in Patients Co-Infected with HCV and HIV: Real-World Heterogeneous Population From the TRIO Network.” Digestive Disease Week. San Diego, California.

3. Schap, David, Guest, Lauren. 2014. “The Loss of Chance Rule in Massachusetts.” Eastern Region NAFE Meetings. Boston, Massachusetts.

4. Schap, David, Guest, Lauren. 2013. “Time Series Analysis of Wage Growth and Discount Rates.” Eastern Region NAFE Meetings. Tampa, Florida.

1

5. Schap, David, Guest, Lauren. 2013. “The Treatment of Income Taxes in Personal Injury Cases: A Summary of Various Rationales from the State Courts.” Allied Social Science Association Annual Meeting. San Diego, California.

Conference Posters

1. Curry, Michael, Bacon, Bruce, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2016. “Effectiveness of 12 or 24 Week LDV-SOF and 12 Week LDV-SOF+RBV in Treatment-Experienced Patients with Cirrhotic, Genotype 1 Hepatitis C: Real-World Experience from the TRIO Network.” International Society for Pharmacoeconomics and Outcomes Research Annual Meeting. Washington, DC.

2. Curry, Michael, Bacon, Bruce, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2016. “Effectiveness of 8 or 12 Week LDV-SOF in Treatment-Naive Patients with Non-Cirrhotic, Genotype 1 Hepatitis C: Real-World Experience from the TRIO Network.” International Society for Pharmacoeconomics and Outcomes Research Annual Meeting. Washington, DC.

3. Afdhal, Nezam, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2016. “Failure with All-Oral DAA Regimens: Real-World Experience from the TRIO Network.” Digestive Disease Week. San Diego, California.

4. Afdhal, Nezam, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2016. “No Effect of Proton Pump Inhibitor (PPI) Use on SVR with Ledipasvir/Sofosbuvir (LDV/SOF): Real-World Data from 2034 Genotype 1 Patients in the TRIO Network.” European Association for the Study of the Liver International Liver Congress. Barcelona, Spain.1

5. Flamm, Steven, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair, Afdhal, Nezam. 2016. “Ledipasvir/Sofosbuvir+/-Ribavirin in HCV Post-Transplant Patients: Real-World Heterogeneous Population from the TRIO Network.” European Association for the Study of the Liver International Liver Congress. Barcelona, Spain.

6. Dieterich, Douglas, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair, Afdhal, Nezam. 2016. “Ledipasvir/Sofosbuvir+/-Ribavirin in Patients Co-Infected with HCV and HIV: Real-World Heterogeneous Population from the TRIO Network.” European Association for the Study of the Liver International Liver Conference. Barcelona, Spain.

7. Flamm, Steven, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair, Afdhal, Nezam. 2016. “Ledipasvir/Sofosbuvir+/-Ribavirin in HCV Post-Transplant Patients: Real-World Heterogeneous Population from the TRIO Network.” International Liver Transplantation Society Annual International Congress. Seoul, Korea.

1 Accepted as a late-breaking abstract

2

8. Afdhal, Nezam, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2016. “Evaluation of Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) for 12 Weeks in a Real-Life Population of Genotype 1a and 1b HCV Patients; Data from the TRIO Network.” The Asian Pacific Association for the Study of the Liver. Tokyo, Japan.

9. Tsai, Naoky, Bacon, Bruce, Curry, Michael, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Younossi, Zobair, Afdhal, Nezam. 2015. “Failure with All-Oral DAA Regimens: Academic and Community Treatment of a Real-World Population from the TRIO Network.” HepDART. Maui, Hawaii.

10. Dieterich, Douglas, Bacon, Bruce, Curry, Michael, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair, Afdhal, Nezam. 2015. “Access to Therapy in Era of All DAA Regimens: Real World Experience from the TRIO Network.” HepDART. Maui, Hawaii.

11. Curry, Michael, Bacon, Bruce, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2015. “Effectiveness of 8 or 12 week LDV-SOF in Treatment-Naïve Patients with Non-Cirrhotic, Genotype 1 Hepatitis C: Real-World Experience from the TRIO network.” American Association for the Study of Liver Diseases Annual Liver Meeting. San Francisco, California.2

12. Curry, Michael, Bacon, Bruce, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2015. “Effectiveness of 12 or 24 week LDV-SOF and 12 week LDV-SOF + RBV in Treatment-Experienced Patients with Cirrhotic, Genotype 1 Hepatitis C: Real-World Experience from the TRIO network.” American Association for the Study of Liver Diseases Annual Liver Meeting. San Francisco, California.

13. Afdhal, Nezam, Bacon, Bruce, Dieterich, Douglas, Flamm, Steven, Guest, Lauren, Kowdley, Kris, Lee, Yoori, Tsai, Naoky, Younossi, Zobair. 2015. “Failure with All-Oral DAA Regimens: Academic and Community Treatment of a Real-World Population from the TRIO Network.” American Association for the Study of Liver Diseases Annual Liver Meeting. San Francisco, California.3

Other Publications

1. Schap, David, Guest, Lauren, Kraynak, Andrew. 2014. “Total Offset and Medical Net Discount Rates: 1981-2012.” CUR Quarterly 34(3): 23.

2 Recipient of the Presidential Poster Distinction Award3 Accepted as a late-breaking abstract

3